drugset / Trial / NCT05256108
Assessment of Abuse Potential of Cebranopadol in Humans
RandomizedCrossoverDouble-blindTreatment
Summary
This study will be conducted to evaluate the abuse potential of single doses of cebranopadol as compared with oxycodone, tramadol and matching placebo in recreational drug users.
Timeline
- Start
- 2022-03-28
- Primary completion
- 2022-07-12
- Completion
- 2022-07-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cebranopadol | Small molecule | 600 ug | Oral |
| Subject | Cebranopadol | Small molecule | 1000 ug | Oral |
| Comparator | Oxycodone | Other / unclassified | 40 mg | Oral |
| Comparator | Tramadol | Other / unclassified | 600 mg | Oral |